Skip to main content
Clinical Trials/CTRI/2023/08/056685
CTRI/2023/08/056685
Completed
未知

Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects - NI

Transformative Learning Solutions Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Transformative Learning Solutions Pvt Ltd
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 31, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Transformative Learning Solutions Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects in age group 18 \- 65 years (both the ages inclusive).
  • 2\.Healthy male \& female subjects with skin types as defined in the population details under appendix 1\.
  • 3\.Subjects in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data.
  • 4\.Subject able to read, understand and sign an appropriate informed consent form indicating her willingness to participate.
  • 5\.Subjects willing to give a voluntary written informed consent.
  • 6\.Subjects willing to maintain the patch test in position for 24 hours.
  • 7\.Subject having not participated in a similar investigation in the past two weeks.
  • 8\.Subjects willing to come for regular follow up visits.
  • 9\.Subjects ready to follow instructions during the study period.

Exclusion Criteria

  • 1\.Subjects with infection, allergy on the tested area.
  • 2\.Subjects with skin allergy, antecedents or atopic subjects.
  • 3\.Athletes and subjects with history of excessive sweating.
  • 4\.Subjects with cutaneous disease which may influence the study result.
  • 5\.Subjects on oral corticosteroid.
  • 6\.Subjects participating in any other cosmetic or therapeutic trial.
  • 7\.Subjects who are currently pregnant or lactating or planning to become pregnant in the period of study.
  • 8\.Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
  • 9\.More than one subject selected/participating from one family/household.
  • 10\.Subjects working with MSCR

Outcomes

Primary Outcomes

Not specified

Similar Trials